Literature DB >> 17400795

Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling.

Jacek Gronwald, Cezary Cybulski, Jan Lubinski, Steven A Narod.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17400795      PMCID： PMC2598043          DOI： 10.1136/jmg.2006.048462

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  3 in total

1.  Cancer incidence in five continents. Volume VIII.

Authors: 
Journal:  IARC Sci Publ       Date:  2002

2.  BRCA1-positive breast cancers in young women from Poland.

Authors:  J Lubiński; B Górski; T Huzarski; T Byrski; J Gronwald; P Serrano-Fernández; W Domagała; M Chosia; M Uciński; E Grzybowska; D Lange; B Maka; A Mackiewicz; A Karczewska; J Breborowicz; K Lamperska; M Stawicka; S Gozdecka-Grodecka; M Bebenek; D Sorokin; A Wojnar; O Haus; J Sir; T Mierzwa; S Niepsuj; K Gugała; S Góźdź; J Sygut; B Kozak-Klonowska; B Musiatowicz; M Posmyk; R Kordek; M Morawiec; O Zambrano; B Waśko; L Fudali; J Skret; D Surdyka; K Urbański; J Mituś; J Ryś; M Szwiec; A Rozmiarek; I Dziuba; P Wandzel; R Wiśniowski; C Szczylik; A Kozak; W Kozłowski; S A Narod
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

3.  Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Authors:  A Smith; A Moran; M C Boyd; M Bulman; A Shenton; L Smith; R Iddenden; E R Woodward; F Lalloo; E R Maher; D G R Evans
Journal:  J Med Genet       Date:  2006-11-01       Impact factor: 6.318
  3 in total
  14 in total

1.  No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.

Authors:  Larissa A Korde; Christine M Mueller; Jennifer T Loud; Jeffery P Struewing; Kathy Nichols; Mark H Greene; Phuong L Mai
Journal:  Breast Cancer Res Treat       Date:  2010-05-11       Impact factor: 4.872

2.  A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.

Authors:  Erica Rowan; Aletta Poll; Steven A Narod
Journal:  J Med Genet       Date:  2007-08       Impact factor: 6.318

3.  Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?

Authors:  Rachel Mitchell; Lela Buckingham; Melody Cobleigh; Jacob Rotmensch; Kelly Burgess; Lydia Usha
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

4.  Antimüllerian hormone levels are lower in BRCA2 mutation carriers.

Authors:  Lauren Johnson; Mary D Sammel; Susan Domchek; Allison Schanne; Maureen Prewitt; Clarisa Gracia
Journal:  Fertil Steril       Date:  2017-05       Impact factor: 7.329

5.  No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families.

Authors:  Henriette Roed Nielsen; Janne Petersen; Lotte Krogh; Mef Nilbert; Anne-Bine Skytte
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

6.  Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.

Authors:  Bess Levin; Denise Lech; Bernard Friedenson
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

7.  Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.

Authors:  Allison W Kurian; Gail D Gong; Esther M John; David A Johnston; Anna Felberg; Dee W West; Alexander Miron; Irene L Andrulis; John L Hopper; Julia A Knight; Hilmi Ozcelik; Gillian S Dite; Carmel Apicella; Melissa C Southey; Alice S Whittemore
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

Review 8.  Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Authors:  Henry T Lynch; Murray Joseph Casey; Carrie L Snyder; Chhanda Bewtra; Jane F Lynch; Matthew Butts; Andrew K Godwin
Journal:  Mol Oncol       Date:  2009-02-21       Impact factor: 6.603

Review 9.  Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Dawn C Allain
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

10.  Principles of genetic predisposition to malignancies.

Authors:  Tadeusz Debniak; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.